JMIR Formative Research (Mar 2021)

Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study

  • Radu, Roxana,
  • Hernández-Ortega, Sara,
  • Borrega, Oriol,
  • Palmeri, Avril,
  • Athanasiou, Dimitrios,
  • Brooke, Nicholas,
  • Chapí, Inma,
  • Le Corvec, Anaïs,
  • Guglieri, Michela,
  • Perera-Lluna, Alexandre,
  • Garrido-Aguirre, Jon,
  • Ryll, Bettina,
  • Nafria Escalera, Begonya

DOI
https://doi.org/10.2196/22695
Journal volume & issue
Vol. 5, no. 3
p. e22695

Abstract

Read online

BackgroundRare disease communities are spread around the globe and segmented by their condition. Little research has been performed on the majority of rare diseases. Most patients who are affected by a rare disease have no research on their condition because of a lack of knowledge due to absence of common groups in the research community. ObjectiveWe aimed to develop a safe and secure community of rare disease patients, without geographic or language barriers, to promote research. MethodsCocreation design methodology was applied to build Share4Rare, with consultation and input through workshops from a variety of stakeholders (patients, caregivers, clinicians, and researchers). ResultsThe workshops allowed us to develop a layered version of the platform based on educating patients and caregivers with publicly accessible information, a secure community for the patients and caregivers, and a research section with the purpose of collecting patient information for analysis, which was the core and final value of the platform. ConclusionsRare disease research requires global collaboration in which patients and caregivers have key roles. Collective intelligence methods implemented in digital platforms reduce geographic and language boundaries and involve patients in a unique and universal project. Their contributions are essential to increase the amount of scientific knowledge that experts have on rare diseases. Share4Rare has been designed as a global platform to facilitate the donation of clinical information to foster research that matters to patients with rare conditions. The codesign methods with patients have been essential to create a patient-centric design.